Your browser doesn't support javascript.
loading
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.
Xiang, Tiandan; Liang, Boyun; Fang, Yaohui; Lu, Sihong; Li, Sumeng; Wang, Hua; Li, Huadong; Yang, Xiaoli; Shen, Shu; Zhu, Bin; Wang, Baoju; Wu, Jun; Liu, Jia; Lu, Mengji; Yang, Dongliang; Dittmer, Ulf; Trilling, Mirko; Deng, Fei; Zheng, Xin.
Afiliación
  • Xiang T; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liang B; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Fang Y; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lu S; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Li S; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Wang H; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li H; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Yang X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Shen S; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Zhu B; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang B; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Wu J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu J; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Lu M; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yang D; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Dittmer U; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Trilling M; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Deng F; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Zheng X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Immunol ; 12: 708523, 2021.
Article en En | MEDLINE | ID: mdl-34220870

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunoglobulina M / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunoglobulina M / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China